Vitality Watch

Dossier pubmed trial early 01-oct-2026
Small or early-phase human trial or pilot study

Associations Between Gut Microbiota and Immune Profiles in Community-Dwelling Older Adults and the Regulatory Role of Polygonatum odoratum.

Key claim: A 90-day randomized, double-blind trial of Polygonatum odoratum (YZG) in community-dwelling adults ≥60 reduced age-related TEMRA T cells, increased Akkermansia and Prevotella 9 while decreasing Klebsiella, and linked these shifts to improved immunity and fewer respiratory infections.

Abstract

Aging is often associated with intestinal microbiota imbalance and immune system degeneration. The dysregulation and crosstalk of these two factors markedly elevate the elderly’s susceptibility to infections and age-related diseases. Polygonatum odoratum, a traditional Chinese medicinal herb, is widely used in geriatric care for its lung-moistening and nourishing effects. However, its potential regulatory roles on the microbiota and immunity in the aging context remain unreported. A total of 140 independently living elderly individuals aged 60 and above were recruited for this study. The randomized, double-blinded study including YZG (P. odoratum) and placebo groups was performed for 90 days’ intervention. Peripheral blood immune cell subsets were analyzed by flow cytometry, and microbial diversity in fecal samples was assessed by 16S rRNA sequencing. Baseline correlation analysis revealed that alterations in gut microbiota were predominantly associated with T cell subsets. Specifically, Akkermansia showed a significant negative correlation with age-related memory T cells, including CD4and CD8TEMRA. Additionally, Klebsiella exhibited a significant positive correlation with partial subsets of CD4TEMRA. After 90-day YZG intervention, the percentage of TEMRA and CD28CD57TEMRA cells were reduced in elderly subjects. The relative abundance of Prevotella 9 and Akkermansia were increased, and the abundance of Klebsiella in the gut microbiota were significantly decreased. Correlation analysis linked YZG-induced gut microbiota changes to improved immunity and fewer respiratory infections. This study demonstrates significant correlations that exist between immunosenescence in T-cell compartments and gut microbial composition, suggesting a potential interplay between microbial health and immune aging. Trial Registration: UMIN Clinical Trials Registry identifier: UMIN000052572.

Why this matters

Most medicine-food homology claims on this page have been reviews, mechanism, or animal work; this is the first entry in the log reporting a double-blind human RCT with immune and microbiome endpoints. The divergence between the trend’s broad ‘food as medicine for aging’ framing and the narrower, 90-day endpoints actually measured (TEMRA subsets, specific genera, self-reported respiratory infections in n=140) is itself the story to track.

Source

Link

Briefing card

Associations Between Gut Microbiota and Immune Profiles in Community-Dwelling Older Adults and the Regulatory Role of Polygonatum odoratum.
Stage: trial early · pubmed · 01-oct-2026

If you are an older adult taking Polygonatum odoratum (Yu Zhu) for immunity, this trial reports gut microbiota shifts and fewer respiratory infections over 90 days — a single modest RCT, not a confirmed long-term effect.

A 90-day randomized, double-blind trial of Polygonatum odoratum (YZG) in community-dwelling adults ≥60 reduced age-related TEMRA T cells, increased Akkermansia and Prevotella 9 while decreasing Klebsiella, and linked these shifts to improved immunity and fewer respiratory infections.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1111/acel.70724

build build 880 · 2bcef25 · 2026-11-18